Preclinical models relevant to Tourette syndrome.

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Animal models are crucial for understanding neuropsychiatric disorders like Tourette Syndrome (TS).
• Existing models primarily focus on antidopaminergic compounds for motor tics, with limited scope for other etiologies.
• Hypotheses involving infectious/immune and neural circuit dysfunctions require more comprehensive preclinical approaches.

Purpose of the Study:

• To describe a comprehensive set of preclinical models for Tourette Syndrome (TS).
• To investigate the hypothesis that primary TS symptoms stem from sensorimotor gating dysfunction.
• To establish models with predictive and construct validity for diverse TS etiologies.

Main Methods:

• Utilizing operational measures of central gating mechanisms, specifically prepulse inhibition (PPI) of the startle reflex.
• Employing PPI-based animal models to assess drug efficacy across different chemical classes.
• Validating models for neurodevelopmental, immune, and genetic factors contributing to TS.

Main Results:

• PPI-based models demonstrate predictive validity for various drug classes.
• These models exhibit construct validity across multiple domains of TS etiology.
• The

Conclusions:

• PPI-based animal models offer significant advantages for TS research.
• These "deficient gating" models provide a robust platform for mechanistic and predictive studies.
• The ultimate success of these models lies in their contribution to identifying TS causes and treatments.